Trial
NCT04341311
Phase I Study of Marizomib + Panobinostat for Children With DIPG
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Dana-Farber Cancer Institute
Collaborators
Celgene; Secura Bio, Inc.
Condition
Diffuse Intrinsic Pontine Glioma
Intervention
Marizomib
Why stopped
Withdrawal of support from BMS
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-15